Exit / M&A
Peplin - LEO Pharma to Acquire Peplin for US$287.5m
LEO Pharma has struck a deal to buy ASX-listed Peplin for roughly US$287.5 million, with its two biggest shareholders, including GBS Venture Partners, backing the transaction.
President and CEO, LEO Pharma A/S
Gitte Aabo
Roles
| Role | Organisation | Sources |
|---|---|---|
| President and CEO | LEO Pharma A/S | GBS Ventures (Thu 12 Nov 2009), GBS Ventures (Thu 3 Sep 2009) |
Coverage
Stories naming Gitte Aabo. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.